Advertisement
U.S. Markets open in 7 hrs 3 mins

Galera Therapeutics, Inc. (GRTX)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Visitors trend2W10W9M
0.0490+0.0005 (+1.03%)
At close: 03:00PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
25,049
46,951
51,226
73,368
70,553
Operating Income
-25,049
-46,951
-51,226
-73,368
-70,553
Net Non Operating Interest Income Expense
-1,741
-9,819
-11,065
-7,162
-3,706
Other Income Expense
-2,315
-2,312
-1
-4
25
Pretax Income
-29,105
-59,082
-62,292
-80,534
-74,234
Tax Provision
-
0
-70
0
-16
Net Income Common Stockholders
-29,105
-59,082
-62,222
-80,534
-74,218
Diluted NI Available to Com Stockholders
-29,105
-59,082
-62,222
-80,534
-74,218
Basic EPS
-1.88
-1.33
-2.30
-3.12
-2.98
Diluted EPS
-1.88
-1.33
-2.30
-3.12
-2.98
Basic Average Shares
37,914
44,549
27,087
25,789
24,870
Diluted Average Shares
37,914
44,549
27,087
25,789
24,870
Total Operating Income as Reported
-27,358
-49,260
-51,226
-73,368
-70,553
Total Expenses
25,049
46,951
51,226
73,368
70,553
Net Income from Continuing & Discontinued Operation
-29,105
-59,082
-62,222
-80,534
-74,218
Normalized Income
-26,790
-56,770
-62,221
-80,530
-74,243
Interest Income
1,051
1,595
506
32
1,174
Interest Expense
2,792
11,414
11,571
7,194
4,880
Net Interest Income
-1,741
-9,819
-11,065
-7,162
-3,706
EBIT
-26,313
-47,668
-50,721
-73,340
-69,354
EBITDA
-26,071
-47,409
-50,607
-72,562
-68,986
Reconciled Depreciation
242
259
114
778
368
Net Income from Continuing Operation Net Minority Interest
-29,105
-59,082
-62,222
-80,534
-74,218
Total Unusual Items Excluding Goodwill
-2,315
-2,312
-1
-4
25
Total Unusual Items
-2,315
-2,312
-1
-4
25
Normalized EBITDA
-23,756
-45,097
-50,606
-72,558
-69,011
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-0.001
0
0.0054